Explore more publications!

Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on November 26, 2025

Saya Biologics and Innovent Biologics announce strategic collaboration to expand access to oncology therapies in Mexico
Visionary Filmmaker Imole Ladipo Unveils Psychological Thriller 8:38 With Award-Winning Creative Team and AAPI Cast
Smartpatient and Daiichi Sankyo Join Forces to Improve Treatment Adherence in Hypercholesterolemia
Trade Capital Corporation® (1TCC®) Secures First Patent, Advancing Capital-Efficient Supply Chain Innovation
Exstent Appoints Matt Thompson as CEO to Drive Global Growth in Personalised Aortic Support
7 Years of Strategic Synergy: iPMI Global and New Frontier Group Renew Alliance to Advance Global IPMI Cost Containment
PubHive Wins 2025 Award for Most Innovative Life Sciences AI Saas
Gene Synthesis Market to Hit USD 6.1 Billion in 2032, Fueled by Therapeutics Demand and Advancements in DNA Technology
International Private Medical Insurance Global Announces Publication of the 2025 Global Provider Network Directory
Psyomics Launches Healthtech Platform to Optimize Neurodiversity Care
Point Of Care Diagnostics Market to Hit USD 7.43 Billion in 2032, Fueled by Home Testing and Rapid Platforms
Neuromonitoring Devices Market Poised for Significant Growth, Projected to Exceed $10 Billion by 2030
Hydreight Reports 132% YoY Revenue Increase in Q3 2025 and Fourth Consecutive Quarter of Profitability, Highlighting Strong Multi-Vertical Performance
Biomed Industries to Present Four Transformative Studies on Alzheimer’s Disease,  Obesity, and Stroke at CTAD 2025
Medical Adhesive Tapes Market Trends and Analysis by Application, Vertical, Region, and Segment Forecast to 2029
Flexible Plastic Packaging Market to Reach USD $232.77 Billion by 2029 at 6.6% CAGR
Healthcare Fabrics Market 2025-2029: Unveiling Growth Developments with the Latest Updates
Tangram Therapeutics reicht Antrag für klinische Studie der Phase 1/2 zu TGM-312 ein, einem neuen RNAi-MASH-Kandidaten, der gerade getestet wird
Tangram Therapeutics soumet une demande d’essai clinique pour une étude de phase 1/2 du TGM-312, un nouveau candidat ARNi expérimental pour le traitement de la MASH
Beyond Air® Announces Transition of Chief Financial Officer

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions